microRNAs as tumor inhibitors, oncogenes, biomarkers for drug efficacy and outcome predictors in lung cancer (Review)
Authors:
Open Access
- 3 February 2012
- journal article
- review article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 5 (4) , 890-894
Abstract
Lung cancer remains the leading cause of cancer-related death worldwide for both men and women, and non-small cell lung cancer (NSCLC) accounts for approximately 80% of all cases. Despite improvements in early diagnosis and newly developed therapies, the 5-year survival rate for NSCLC patients remains low (15%). Therapy in NSCLC has reached a plateau. Understanding genomic medicine may provide insight into the oncogenesis of lung cancer and open the door to molecular diagnosis, new biomarkers and a more accurate prognosis of lung cancer. It is well known that almost half of the genes regulated by microRNAs (miRNAs) are located in cancer-associated genomic regions. In the present study, we discuss the potential of miRNAs to function as suppressors and biomarkers for chemoresistance and prognosis of lung cancer.Keywords
This publication has 46 references indexed in Scilit:
- Implication of microRNAs in drug resistance for designing novel cancer therapyDrug Resistance Updates, 2010
- RETRACTED: miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 DownregulationCancer Cell, 2009
- MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokersProceedings of the National Academy of Sciences, 2009
- Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseasesCell Research, 2008
- Circulating microRNAs as stable blood-based markers for cancer detectionProceedings of the National Academy of Sciences, 2008
- Suppression of non-small cell lung tumor development by the let-7 microRNA familyProceedings of the National Academy of Sciences, 2008
- A microRNA component of the p53 tumour suppressor networkNature, 2007
- MicroRNA Signatures in Human CancersNature Reviews Cancer, 2006
- Oncomirs — microRNAs with a role in cancerNature Reviews Cancer, 2006
- MicroRNA expression profiles classify human cancersNature, 2005